文献速递临床免疫临床生化

高剂量生物素治疗致内分泌生化假性异常及N5清除法验证

High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
PubMed 文献 · Clin Chem Lab Med · 2017-01-01

研究纳入23例接受高剂量生物素的MS患者与健康志愿者血浆及39例未补充生物素患者,评估生物素对多种激素免疫分析的干扰,并验证链霉亲和素包被微粒清除法(N5)。高生物素血浆激素结果多数异常,N5处理后恢复正常,未补充者结果不受影响。

要点

  • 高剂量生物素可致多种激素免疫分析结果假性异常,存在误诊风险。
  • N5清除法可有效去除生物素,使多数激素结果恢复正常。
  • 对未补充生物素患者,N5仅使PTH结果下降8.4%,其余激素不受影响。

核心结论

  • 高生物素浓度干扰多数链霉亲和素-生物素激素免疫分析,N5中和法可高效抑制该干扰。

研究设计与样本

  • 研究检测23例接受高剂量生物素的MS患者与健康志愿者血浆及39例未补充生物素患者,比较N5处理前后结果。

主要发现

  • 23例高生物素血浆生物素浓度为31.7至1160 µg/L。
  • N5处理后除2例(8.3与27.6 μg/L)外生物素均低于检测限。
  • 多数激素结果异常但N5后恢复正常。
  • 替代方法结果均正常,仅2例PTH轻度升高。
  • 39例未补充者N5后除PTH下降8.4%外其余激素不受影响。

临床怎么用

  • 对接受高剂量生物素治疗者,检验前应评估生物素干扰并可采用N5法清除后再测激素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-dose biotin therapy is beneficial in progressive multiple sclerosis (MS) and is expected to be adopted by a large number of patients. Biotin therapy leads to analytical interference in many immunoassays that utilize streptavidin-biotin capture techniques, yielding skewed results that can mimic various endocrine disorders. We aimed at exploring this interference, to be able to remove biotin and avoid misleading results. METHODS: We measured free triiodothyronine (fT3), free thyroxine (fT4), thyroid-stimulating hormone (TSH), parathyroid homrone (PTH), 25-hydroxyvitamin D (25OHD), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, C-peptide, cortisol (Roche Diagnostics assays), biotin and its main metabolites (liquid chromatography tandem mass spectrometry) in 23 plasmas from MS patients and healthy volunteers receiving high-dose biotin, and in 39 biotin-unsupplemented patients, before and after a simple procedure (designated N5) designed to remove biotin by means of streptavidin-coated microparticles. We also assayed fT4, TSH and PTH in the 23 high-biotin plasmas using assays not employing streptavidin-biotin binding. RESULTS: The biotin concentration ranged from 31.7 to 1160 µg/L in the 23 high-biotin plasmas samples. After the N5 protocol, the biotin concentration was below the detection limit in all but two samples (8.3 and 27.6 μg/L). Most hormones results were abnormal, but normalized after N5. All results with the alternative methods were normal except two slight PTH elevations. In the 39 biotin-unsupplemented patients, the N5 protocol did not affect the results for any of the hormones, apart from an 8.4% decrease in PTH. CONCLUSIONS: We confirm that most streptavidin-biotin hormone immunoassays are affected by high biotin concentrations, leading to a risk of misdiagnosis. Our simple neutralization method efficiently suppresses biotin interference.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Piketty ML, Prie D, Sedel F, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med. 2017. PMID: 28222020. doi:10.1515/cclm-2016-1183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。